NDC 62542-015-30
Amphetamine Extended-Release 9.4 mg/1
Amphetamine Extended-Release · TABLET, ORALLY DISINTEGRATING
Amphetamine Extended-Release is a prescription stimulant medication used to treat attention-deficit/hyperactivity disorder (ADHD) and narcolepsy. This orally disintegrating tablet releases the medication gradually over time to help improve focus, attention, and wakefulness.
Key Facts
- Brand Name
- Amphetamine Extended-Release
- Generic Name
- Amphetamine Extended-Release
- NDC Code (Package)
62542-015-30- NDC Code (Product)
62542-015- Manufacturer
- Neos Therapeutics, LP
- Strength
- 9.4 mg/1
- Dosage Form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Marketing Status
- DEA Schedule
- Schedule II (Controlled)
- Application #
- NDA204326
- Drug Class
- Central Nervous System Stimulant [EPC]
- Marketing Start
- 09/01/2025
Recall History
No Recall HistoryView Full Drug Page
Amphetamine Extended-Release — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.